|
Volume
20 Number 8
31 August 2018
|
|
Home
>
Publications
>
Current
Neuro-Oncology >
Volume
20, Year 2018 >
Number 8, 31 August
|
|
|
|
|
|
Kang Z, Yang S, Zhang H, Zhou Q, Chen J, Li Y, Kang X, Li S, Li W.
Extracranial metastasis of
anaplastic oligoastrocytoma.
Cancer Biol Med. 2018
Aug 1, 2018;15(3):311-313→.
doi: 10.20892/j.issn.2095-3941.2017.0181→.
PMID: 30197798→.
Case report. ˍ
|
|
|
|
Lee
JH, Lee JE, Kahng JY, Kim SH, Park JS, Yoon SJ, Um JY, Kim WK, Lee
JK, Park J, Kim EH, Lee JH, Lee JH, Chung WS, Ju YS, Park SH,
Chang JH, Kang SG, Lee JH.
Human
glioblastoma arises from subventricular zone cells with low-level
driver mutations.
Nature.
2018 Aug 1. 2018;560(7717):243-247→.
doi: 10.1038/s41586-018-0389-3→.
PMID: 30069053→.
Laboratory investigation. ˍ
|
|
|
|
Lukas RV, Rodon J, Becker K, Wong ET, Shih K, Touat M, Fassò
M, Osborne S, Molinero L, O'Hear C, Grossman W, Baehring J.
Clinical activity and safety of
atezolizumab in patients with recurrent glioblastoma.
J
Neurooncol. 2018 Aug 2, 2018;140(2):317-328→.
doi: 10.1007/s11060-018-2955-9→.
PMID: 30073642→.
Interventional study. ˍ
|
|
|
|
Lee C, Robinson M, Willerth SM.
Direct
Reprogramming of Glioblastoma Cells into Neurons Using Small
Molecules.
ACS Chem Neurosci. 2018 Aug 9,
2018;9(12):3175-3185→.
doi: 10.1021/acschemneuro.8b00365→.
PMID: 30091580→.
Laboratory
investigation. ˍ
|
|
|
|
Witzel
I, Laakmann E, Weide R, Neunhöffer T, Park-Simon TJ, Schmidt
M, Fasching PA, Hesse T, Polasik A, Mohrmann S, Würschmidt F,
Schem C, Bechtner C, Würstlein R, Fehm T, Möbus V,
Burchardi N, Loibl S, Müller V.
Treatment
and outcomes of patients in the Brain Metastases in Breast Cancer
Network Registry.
Eur
J Cancer. 2018 Aug 9, 2018;102:1-9→.
doi: 10.1016/j.ejca.2018.07.004→.
PMID: 30099223→.
Observational study. ˍ
|
|
|
|
Kondyli M, Larouche V, Saint-Martin C, Ellezam B, Pouliot L,
Sinnett D, Legault G, Crevier L, Weil A, Farmer JP, Jabado N,
Perreault S.
Trametinib for
progressive pediatric low-grade gliomas.
J
Neurooncol. 2018 Aug 10, 2018;140(2):435-444→.
doi: 10.1007/s11060-018-2971-9→.
PMID: 30097824→.
Observational
study. ˍ
|
|
|
|
AlHarbi M, Ali Mobark N, AlMubarak L, Aljelaify R, AlSaeed M,
Almutairi A, Alqubaishi F, Hussain ME, Balbaid AAO, Said Marie A,
AlSubaie L, AlShieban S, alTassan N, Ramkissoon SH, Abedalthagafi
M.
Durable Response to Nivolumab in
a Pediatric Patient with Refractory Glioblastoma and
Constitutional Biallelic Mismatch Repair Deficiency.
Oncologist.
2018 Aug 13, 2018;23(12):1401-1406→.
doi: 10.1634/theoncologist.2018-0163→.
PMID: 30104292→.
Case report.
ˍ
|
|
|
|
Chongsathidkiet P, Jackson C, Koyama S, Loebel F, Cui X, Farber
SH, Woroniecka K, Elsamadicy AA, Dechant CA, Kemeny HR,
Sanchez-Perez L, Cheema TA, Souders NC, Herndon JE, Coumans JV,
Everitt JI, Nahed BV, Sampson JH, Gunn MD, Martuza RL, Dranoff G,
Curry WT, Fecci PE.
Sequestration
of T cells in bone marrow in the setting of glioblastoma and other
intracranial tumors.
Nat Med. 2018 Aug 13,
2018;24(9):1459-1468→.
doi: 10.1038/s41591-018-0135-2→.
PMID: 30104766→.
Laboratory
investigation. ˍ
|
|
|
*
|
van
den Bent MJ, Klein M, Smits M, Reijneveld JC, French PJ, Clement
P, de Vos FYF, Wick A, Mulholland PJ, Taphoorn MJB, Lewis J,
Weller M, Chinot OL, Kros JM, de Heer I, Verschuere T, Coens C,
Golfinopoulos V, Gorlia T, Idbaih A.
Bevacizumab
and temozolomide in patients with first recurrence of WHO grade II
and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised
controlled phase 2 EORTC trial.
Lancet
Oncol. 2018 Aug 13, 2018;19(9):1170-1179→.
doi: 10.1016/S1470-2045(18)30362-0→.
PMID: 30115593→.
Interventional study. ˍ
|
|
|
|
Hao
J, Godley A, Shoemake JD, Han Z, Magnelli A, Yu JS.
The
effects of extra high dose rate irradiation on glioma stem-like
cells.
PLoS
One. 2018 Aug 17, 2018;13(8):e0202533→.
doi: 10.1371/journal.pone.0202533→.
PMID:
30118510→.
Laboratory
investigation. ˍ
|
|
|
|
Patel
NV, Schneider JR, Kwan K, Boockvar JA.
The
Glioblastoma Cell Ecosystem: Signals Between Progenitors and
Progeny.
Neurosurgery.
2018 Aug 17, 2018;83(3):E95→.
doi: 10.1093/neuros/nyy296→.
PMID:
30125029→.
Comment.
ˍ
Refers
to: Wang
X et al, Reciprocal Signaling between Glioblastoma Stem Cells and
Differentiated Tumor Cells Promotes Malignant Progression. Cell
Stem Cell. 2018 Apr 5, 2018;22(4):514-528.e5→.
doi: 10.1016/j.stem.2018.03.011→.
PMID: 29625067→.
Laboratory investigation.
ˍ
|
|
|
|
Press
RH, Zhang C, Cassidy RJ, Ferris MJ, Zhong J, Steuer CE, Pillai RN,
Owonikoko TK, Kahn S, Ramalingam SS, Patel PR, Curran WJ, Shu HG,
Sica GL, Higgins KA.
Targeted
Sequencing and Intracranial Outcomes of Patients With Lung
Adenocarcinoma Brain Metastases Treated With Radiotherapy.
Cancer.
2018 Aug 18,
2018;124(17):3586-3595→.
doi:
10.1002/cncr.31589→.
PMID:
30120912→.
Observational
study. ˍ
|
|
|
|
Guzauskas
GF, Salzberg M, Wang BC.
Estimated
lifetime survival benefit of tumor treating fields and
temozolomide for newly diagnosed glioblastoma patients.
CNS
Oncol. 2018 Aug 20, 2018;7(3):CNS23→.
doi: 10.2217/cns-2018-0010→.
PMID: 30124334→.
Observational
study. ˍ
|
|
|
|
Maxwell
R, Luksik AS, Garzon-Muvdi T, Yang W, Huang J, Bettegowda C, Jallo
GI, Terezakis SA, Groves M.
Population-based
Study Determining Predictors of Cancer-Specific Mortality and
Survival in Pediatric High-grade Brainstem Glioma.
World
Neurosurg. 2018 Aug 20, 2018;119:e1006-e1015→.
doi: 10.1016/j.wneu.2018.08.044→.
PMID: 30138731→.
Observational
study. ˍ
|
|
|
|
Blakeley
JO, Grossman SA, Chi AS, Mikkelsen T, Rosenfeld MR, Ahluwalia MS,
Nabors LB, Eichler A, Garcia-Ribas I, Desideri S, Ye X.
Phase
II Study of Iniparib with Concurrent Chemoradiation in Patients
with Newly Diagnosed Glioblastoma.
Clin
Cancer Res. 2018 Aug 21, 2019;25(1):73-79→.
doi: 10.1158/1078-0432.CCR-18-0110→.
PMID: 30131387→.
Interventional study. ˍ
|
|
|
|
Rice
SR, Bentzen SM, Hanna A, Choi E, Boggs DH, Kwok Y, Hyder J,
Feigenberg SJ, Regine WF, Woodworth GF, Eisenberg HM, Yu C,
Biggins TF, Barnholtz-Sloan JS, Sperduto PW, Weltman E, Mehta MP.
Prognostic
models for patients with brain metastases after stereotactic
radiosurgery with or without whole brain radiotherapy: a
validation study.
J
Neurooncol. 2018 Aug 21, 2018;140(2):341-349→.
doi: 10.1007/s11060-018-2958-6→.
PMID: 30132164→.
Observational
study. ˍ
|
|
|
|
Taylor
JW, Parikh M, Phillips JJ, James CD, Molinaro AM, Butowski NA,
Clarke JL, Oberheim-Bush NA, Chang SM, Berger MS, Prados M.
Phase-2
trial of palbociclib in adult patients with recurrent RB1-positive
glioblastoma.
J
Neurooncol. 2018 Aug 27, 2018;140(2):477-483→.
doi: 10.1007/s11060-018-2977-3→.
PMID: 30151703→.
Interventional study. ˍ
|
|
|
|
Bota
DA, Chung J, Dandekar M, Carrillo JA, Kong XT, Fu BD, Hsu FP,
Schönthal AH, Hofman FM, Chen TC, Zidovetzki R, Pretto C,
Strik A, Schijns VE, Stathopoulos A.
Phase
II study of ERC1671 plus bevacizumab versus bevacizumab plus
placebo in recurrent glioblastoma: interim results and
correlations with CD4+
T-lymphocyte
counts.
CNS
Oncol. 2018 Aug 29, 2018;7(3):CNS22→.
doi: 10.2217/cns-2018-0009→.
PMID: 30157683→.
Interventional
study. ˍ
|
|
|
|
Wood
H.
Addition
of bevacizumab fails to improve on temozolomide alone for glioma
therapy.
Nat
Rev Neurol. 2018 Aug 29, 2018;14(10):570→.
doi: 10.1038/s41582-018-0067-y→.
PMID: 30158560→.
Comment.
ˍ
Refers
to: Van
den Bent MJ et al.,Bevacizumab and temozolomide in patients with
first recurrence of WHO grade II and III glioma, without 1p/19q
co-deletion (TAVAREC): a randomised controlled phase 2 EORTC
trial. Lancet Oncol. 2018 Aug 13, 2018;19(9):1170-1179→.
doi: 10.1016/S1470-2045(18)30362-0→.
PMID: 30115593→.
Interventional
study. ˍ
|
|
|
|
Dotson J, Nijim A, Denning KL, Shweihat Y, Lebowicz Y.
A
Rare Case of Metastases from a High-grade Astrocytoma to the
Pleura, Bones, and Liver within Six Months of Diagnosis.
Cureus.
2018 Aug 30, 2018;10(8):e3234→.
doi: 10.7759/cureus.3234→.
PMID: 30410840→.
Case report. ˍ
|
|
|
|
Das
M.
Iniparib
improves survival in newly diagnosed glioblastoma.
Lancet
Oncol. 2018 Aug 31, 2018;19(10):e514→.
doi: 10.1016/S1470-2045(18)30665-X→.
PMID: 30177496→.
Comment.
ˍ
Refers
to:
Blakeley
JO et al., Phase II Study of Iniparib with Concurrent
Chemoradiation in Patients with Newly Diagnosed Glioblastoma. Clin
Cancer Res. 2018 Aug 21, 2019;25(1):73-79→.
doi: 10.1158/1078-0432.CCR-18-0110→.
PMID: 30131387→.
Interventional
study. ˍ
|
|
|
|
|
|
|
|
|
